Literature DB >> 19266249

The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging.

Andrew J Yoon1, Rowlens M Melduni, Shelly-Ann Duncan, Robert J Ostfeld, Mark I Travin.   

Abstract

BACKGROUND: The effect of beta (beta) blockers on the accuracy, particularly the sensitivity, of vasodilator radionuclide myocardial perfusion imaging (MPI) is not entirely clear. This study aimed to further assess the effect of beta-blockers on the ability of MPI to identify significant and high-risk coronary artery disease (CAD). METHODS AND
RESULTS: For 555 patients who underwent vasodilator MPI and had coronary angiography within 90 days, global and per-vessel sensitivities and specificities were calculated, and were found to be similar between patients taking beta-blockers and those who were not. beta-blockers did not decrease the ability to detect patients with multivessel disease. Summed stress scores and summed rest scores were likewise similar in both groups. To account in part for catheterization referral bias and the potential of false-negative MPI studies in patients receiving beta-blockers, survival analysis was performed on 2646 patients with normal MPI studies who did not undergo cardiac catheterization and failed to demonstrate significant mortality difference related to the taking of beta-blockers.
CONCLUSIONS: beta-blocker therapy does not diminish the ability of vasodilator stress MPI to detect clinically significant CAD, nor hide the mortality risk of patients with normal studies not referred for catheterization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266249     DOI: 10.1007/s12350-009-9066-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  36 in total

1.  Effects of therapy with beta-blocker agents on myocardial perfusion and outcome.

Authors:  Deval Mehta; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

2.  Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis.

Authors:  C Kim; Y S Kwok; P Heagerty; R Redberg
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

3.  "False-positive" myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonography studies.

Authors:  E Verna; L Ceriani; L Giovanella; G Binaghi; S Garancini
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

4.  Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.

Authors:  G V Heller; S D Herman; M I Travin; J I Baron; C Santos-Ocampo; J R McClellan
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

5.  Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.

Authors:  M S Verani; J J Mahmarian; J B Hixson; T M Boyce; R A Staudacher
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

6.  Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.

Authors:  G A Beller; H H Holzgrefe; D D Watson
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

7.  Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery.

Authors:  C A Boucher; D C Brewster; R C Darling; R D Okada; H W Strauss; G M Pohost
Journal:  N Engl J Med       Date:  1985-02-14       Impact factor: 91.245

Review 8.  Neurogenic regulation of coronary vasomotor tone.

Authors:  G Heusch; B D Guth
Journal:  Eur Heart J       Date:  1989-11       Impact factor: 29.983

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia.

Authors:  Morten Bøttcher; Jens Refsgaard; Mette M Madsen; Flemming Randsbaek; Anne Kaltoft; Hans Erik Bøtker; Torsten Toftegaard Nielsen
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

View more
  10 in total

Review 1.  Quantitative and qualitative analysis and interpretation of CT perfusion imaging.

Authors:  Carolina Valdiviezo; Marietta Ambrose; Vishal Mehra; Albert C Lardo; Joao A C Lima; Richard T George
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

Review 2.  CT-based myocardial perfusion imaging-practical considerations: acquisition, image analysis, interpretation, and challenges.

Authors:  Vishal C Mehra; Marietta Ambrose; Carolina Valdiviezo-Schlomp; Karl H Schuleri; Albert C Lardo; Joao A C Lima; Richard T George
Journal:  J Cardiovasc Transl Res       Date:  2011-06-14       Impact factor: 4.132

Review 3.  CT perfusion: ready for prime time.

Authors:  Marietta S Ambrose; Carolina Valdiviezo; Vishal Mehra; Albert C Lardo; Joao A C Lima; Richard T George
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

4.  The significance of transient ischemic dilation in the setting of otherwise normal SPECT radionuclide myocardial perfusion images.

Authors:  Carolina Valdiviezo; Apurva A Motivala; Rory Hachamovitch; Murthy Chamarthy; Pablo C Navarro; Robert J Ostfeld; Mimi Kim; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2011-02-15       Impact factor: 5.952

5.  Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study.

Authors:  Luise Holzhauser; Ninel Hovnanians; Parham Eshtehardi; M Khalid Mojadidi; Yi Deng; David Goodman-Meza; Pavlos Msaouel; Yi-An Ko; Ronald Zolty
Journal:  Heart Vessels       Date:  2017-03-16       Impact factor: 2.037

6.  Current status of cardiac CT for the detection of myocardial ischemia.

Authors:  A Schuhbäck; M Marwan; R C Cury; S Achenbach
Journal:  Herz       Date:  2013-06       Impact factor: 1.443

7.  Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

8.  Non-invasive assessment of coronary artery disease with CT coronary angiography and SPECT: a novel dose-saving fast-track algorithm.

Authors:  Aju P Pazhenkottil; Bernhard A Herzog; Lars Husmann; Ronny R Buechel; Irene A Burger; Ines Valenta; Ulf Landmesser; Christophe A Wyss; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-30       Impact factor: 9.236

9.  The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging.

Authors:  C Hoffmeister; R Preuss; R Weise; W Burchert; O Lindner
Journal:  J Nucl Cardiol       Date:  2014-08-15       Impact factor: 5.952

10.  Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? A randomized clinical trial.

Authors:  Babak Fallahi; Davood Beiki; Saeed Akbarpour; Ali Gholamrezanezhad; Armaghan Fard-Esfahani; Fariba Akhzari; Sina Izadyar; Javad Esmaeli; Mohsen Saghari; Mohammad Eftekhari
Journal:  Daru       Date:  2013-01-15       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.